...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Shareholders

I don't see the confusion.  Eastern got ZCC shares in the private placement.   You have ZCC shares. I have ZCC shares.  Everybody has ZCC shares.

 

Share
New Message
Please login to post a reply